Lou Peian, Chen Peipei, Zhang Pan, Yu Jiaxi, Wang Yong, Chen Na, Zhang Lei, Wu Hongmin, Zhao Jing
Dept. of Control and Prevention of Chronic Non-communicable Diseases of Xuzhou Unit for Disease Control and Prevention, Xuzhou, China.
Dept. of Respiratory Medicine of the Affiliated Hospital of Xuzhou Medical College, Xuzhou China.
Iran J Public Health. 2016 Feb;45(2):146-57.
Depression and smoking decrease health status in Chronic Obstructive Pulmonary Disease (COPD), but the combined effect of the two factors is unknown. This study aimed to assess the interactive effects of depression and smoking on the severity of patients with COPD.
A prospective cohort study including 2,268 patients with COPD was conducted in seven rural communities from May 2008 to May 2012. The relationships between the BODE (body mass index, airflow obstruction, dyspnea, and exercise capacity) index and depression and nicotine addiction were assessed. The product of depression and smoking was added to the logistic regression model to evaluate the multiplicative interaction and relative excess risk of interaction (RERI). The Attributable Proportion (AP) of interaction and the synergy index (S) was applied to evaluate the additive interaction of two factors.
The severity of COPD in patients with depressive symptoms who never smoked was increased 1.74-fold and in smoking patients it increased by 6.08-fold. Highly addicted smokers with depressive symptoms had a nearly 40-fold increase in severity (all P<0.001). The increased values of the BODE index, HADS-D and Fagerström score also correlated positively (P<0.001). The co-presence of depressive symptoms and smoking significantly increased the BODE index by 11.99-fold with significant biological interactions, relative excess risk of interaction (RERI) was 12.12, the biological interactions were increased with increasing nicotine addiction.
Patients with depressive symptoms who also smoke have an increased risk of severity from COPD interaction effects. The risk for severity of COPD and depressive symptoms increased with increasing the severity of nicotine addiction.
抑郁症和吸烟会降低慢性阻塞性肺疾病(COPD)患者的健康状况,但这两个因素的综合影响尚不清楚。本研究旨在评估抑郁症和吸烟对COPD患者病情严重程度的交互作用。
2008年5月至2012年5月在7个农村社区进行了一项前瞻性队列研究,纳入2268例COPD患者。评估了BODE(体重指数、气流阻塞、呼吸困难和运动能力)指数与抑郁症和尼古丁成瘾之间的关系。将抑郁症和吸烟的乘积纳入逻辑回归模型,以评估相乘交互作用和交互作用的相对超额风险(RERI)。应用交互作用的归因比例(AP)和协同指数(S)来评估两个因素的相加交互作用。
从不吸烟的抑郁症状患者COPD严重程度增加1.74倍,吸烟患者增加6.08倍。有抑郁症状的高成瘾性吸烟者严重程度增加近40倍(均P<0.001)。BODE指数、医院焦虑抑郁量表-抑郁分量表(HADS-D)和法格斯特罗姆评分的增加值也呈正相关(P<0.001)。抑郁症状和吸烟同时存在使BODE指数显著增加11.99倍,具有显著的生物学交互作用,交互作用的相对超额风险(RERI)为12.12,随着尼古丁成瘾性增加,生物学交互作用增强。
有抑郁症状且吸烟的患者因COPD交互作用导致病情严重程度增加的风险升高。COPD严重程度和抑郁症状的风险随着尼古丁成瘾严重程度的增加而增加。